AYNESSA MONDLAK: Open Payments
NPI 1407977192 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 9 payments from 7 companies in 2025. Trend: 2023 $346 · 2024 $181 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ABBVIE INC. | 3 | $94 |
| E.R. Squibb & Sons, L.L.C. | 1 | $58 |
| Janssen Biotech, Inc. | 1 | $24 |
| Galvanize Therapeutics, Inc | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: NATRELLE SALINE-FILLED BREAST IMPLANTS, REBLOZYL, TALVEY, ALIYA SYSTEM, KISQALI, KEYTRUDA, ALLODERM.
Industry payments across WV — which companies pay providers there.
